Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment

被引：0
作者：
Marzio E.E. Sabbioni
Hans Peter Siegrist
Marisa Bacchi
Jürg Bernhard
Monica Castiglione
Beat Thürlimann
Hervé Bonnefoi
Lucien Perey
Richard Herrmann
Aron Goldhirsch
Christoph Hürny
机构：
[1] University HospitalInselspital,Medical Division Lory
[2] Medizinisch-chemisches Labor,Haus
[3] IBCSG,Medical Department C
[4] Biometrics,Gynecology Department
[5] Ares-Serono International S.A.,Oncology Department
[6] Kantonsspital,Oncology Division
[7] University Hospital Geneva,undefined
[8] University Hospital Lausanne,undefined
[9] University Hospital Basel,undefined
[10] Bürgerspital,undefined
来源：
Breast Cancer Research and Treatment | 2000年 / 59卷
关键词：
breast cancer; cellular immunity; β; -microglobulin; sIL-2r; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: The association of known prognostic factors with immune cell counts and β2-microglobulin and soluble IL-2 receptor (sIL-2r) serum levels as markers of activation of the immune system was investigated in breastcancer.
引用
收藏
页码：279 / 287
页数：8
相关论文
共 50 条
  • [21] Optimal timing of adjuvant treatment in patients with early breast cancer
    Necati Alkis
    Ayse G. Durnali
    Ulku Y. Arslan
    Murat Kocer
    Fatih O. Onder
    Saadet Tokluoglu
    Gokhan Celenkoglu
    Sadik Muallaoglu
    Gungor Utkan
    Arife Ulas
    Kadri Altundag
    Medical Oncology, 2011, 28 : 1255 - 1259
  • [22] PROGNOSTIC FACTORS IN NODE POSITIVE PRIMARY BREAST-CANCER PATIENTS TREATED WITH ADJUVANT CMF
    CAMPORA, E
    PRONZATO, P
    AMOROSO, D
    BERTELLI, GF
    VENTURINI, M
    BALDINI, E
    BRUNETTI, I
    SERTOLI, MR
    CONTE, P
    ROSSO, R
    ANTICANCER RESEARCH, 1992, 12 (05) : 1555 - 1558
  • [23] Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer
    Wunderle, Marius
    Pretscher, Jutta
    Brucker, Sara Y.
    Volz, Bernhard
    Hartmann, Arndt
    Fiessler, Cornelia
    Hein, Alexander
    Haeberle, Lothar
    Jud, Sebastian M.
    Lux, Michael P.
    Janni, Wolfgang
    Loehberg, Christian R.
    Hartkopf, Andreas D.
    Walter, Christina B.
    Baake, Gerold
    Fridman, Alexander
    Malter, Wolfram
    Wuerstlein, Rachel
    Harbeck, Nadia
    Hoffmann, Oliver
    Kuemmel, Sherko
    Martin, Bernhard
    Thomssen, Christoph
    Graf, Heiko
    Wolf, Christopher
    Bayer, Christian M.
    Hack, Carolin C.
    Almstedt, Katrin
    Gass, Paul
    Heindl, Felix
    Brodkorb, Tobias F.
    Nabieva, Naiba
    Lindner, Christoph
    Kolberg, Hans-Christian
    Krabisch, Petra
    Weigel, Michael
    Steinfeld-Birg, Dieter
    Kohls, Andreas
    Brucker, Cosima
    Schulz, Volker
    Fischer, Gunnar
    Pelzer, Volker
    Wallwiener, Diethelm
    Rack, Brigitte
    Fehm, Tanja
    Rody, Achim
    Maass, Nicolai
    Beckmann, Matthias W.
    Fasching, Peter A.
    Rauh, Claudia
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (02) : 453 - 461
  • [24] Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer
    Ligibel, Jennifer A.
    Winer, Eric P.
    WOMENS HEALTH, 2006, 2 (01) : 89 - 97
  • [25] Prognostic factors influencing prognosis in early breast cancer patients
    Najafi, Safa
    Sadeghi, Masoud
    Abasvandi, Fereshteh
    Shajari, Mohammad Reza
    Mohebi, Kamran
    Ghandchi, Helen
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2019, 18 (02): : 82 - 88
  • [26] Prognostic factors of early breast cancer
    Almagro, Elena
    Gonzalez, Cynthia S.
    Espinosa, Enrique
    MEDICINA CLINICA, 2016, 146 (04): : 167 - 171
  • [27] Prognostic factors in primary breast cancer patients
    Gohring, UJ
    Scharl, A
    MEDIZINISCHE WELT, 1998, 49 (08): : 359 - 366
  • [28] Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer
    Marius Wunderle
    Jutta Pretscher
    Sara Y. Brucker
    Bernhard Volz
    Arndt Hartmann
    Cornelia Fiessler
    Alexander Hein
    Lothar Häberle
    Sebastian M. Jud
    Michael P. Lux
    Wolfgang Janni
    Christian R. Loehberg
    Andreas D. Hartkopf
    Christina B. Walter
    Gerold Baake
    Alexander Fridman
    Wolfram Malter
    Rachel Wuerstlein
    Nadia Harbeck
    Oliver Hoffmann
    Sherko Kümmel
    Bernhard Martin
    Christoph Thomssen
    Heiko Graf
    Christopher Wolf
    Christian M. Bayer
    Carolin C. Hack
    Katrin Almstedt
    Paul Gass
    Felix Heindl
    Tobias F. Brodkorb
    Naiba Nabieva
    Christoph Lindner
    Hans-Christian Kolberg
    Petra Krabisch
    Michael Weigel
    Dieter Steinfeld-Birg
    Andreas Kohls
    Cosima Brucker
    Volker Schulz
    Gunnar Fischer
    Volker Pelzer
    Diethelm Wallwiener
    Brigitte Rack
    Tanja Fehm
    Achim Rody
    Nicolai Maass
    Matthias W. Beckmann
    Peter A. Fasching
    Claudia Rauh
    Breast Cancer Research and Treatment, 2019, 174 : 453 - 461
  • [29] PROGNOSTIC FACTORS - STAGE AND RECEPTOR STATUS IN BREAST-CANCER
    DONEGAN, WL
    CANCER, 1992, 70 (06) : 1755 - 1764
  • [30] Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors
    Schilder, C. M. T.
    Seynaeve, C.
    Linn, S. C.
    Boogerd, W.
    Beex, L. V. A. M.
    Gundy, C. M.
    Nortier, J. W. R.
    van de Velde, C. J. H.
    van Dam, F. S. A. M.
    Schagen, S. B.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2010, 76 (02) : 133 - 141
12345